Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder

[1]  Matthew D. Bramlett,et al.  The Co-Occurrence of Autism Spectrum Disorder in Children With ADHD , 2020, Journal of attention disorders.

[2]  Maureen S. Durkin,et al.  Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[3]  P. Rudzki,et al.  Incurred sample reanalysis: adjusted procedure for sample size calculation. , 2017, Bioanalysis.

[4]  S. Koizumi,et al.  Astrocyte‐mediated synapse remodeling in the pathological brain , 2017, Glia.

[5]  Geir Bjorklund,et al.  Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children , 2017, Metabolic Brain Disease.

[6]  N. Meguid,et al.  Dietary adequacy of Egyptian children with autism spectrum disorder compared to healthy developing children , 2017, Metabolic Brain Disease.

[7]  Aribert Rothenberger,et al.  Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism , 2017, Translational Psychiatry.

[8]  Geir Bjorklund,et al.  Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet , 2016, Metabolic Brain Disease.

[9]  M. Chartrand,et al.  Nutritional and Environmental Influences on Autism Spectrum Disorder , 2016 .

[10]  A. El-Ansary.  Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients , 2016, Data in brief.

[11]  J. A. Van de Water,et al.  Risk factors in autism: Thinking outside the brain. , 2016, Journal of autoimmunity.

[12]  L. Schieve,et al.  Estimated Prevalence of Autism and Other Developmental Disabilities Following Questionnaire Changes in the 2014 National Health Interview Survey. , 2015, National health statistics reports.

[13]  Carla V. Sesarini.  GABAergic neurotransmission alterations in autism spectrum disorders , 2015 .

[14]  D. Angelaki,et al.  A computational perspective on autism , 2015, Proceedings of the National Academy of Sciences.

[15]  Fei Du,et al.  Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo , 2015, NeuroImage.

[16]  Dandan Sun,et al.  GABA receptors in brain development, function, and injury , 2015, Metabolic Brain Disease.

[17]  A. El-Ansary,et al.  GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders , 2014, Journal of Neuroinflammation.

[18]  S. Bashir,et al.  Autism Spectrum Disorder: Main Problem Waiting for Solution in Kingdom of Saudi Arabia , 2014 .

[19]  M. Scanziani,et al.  Equalizing Excitation-Inhibition Ratios across Visual Cortical Neurons , 2014, Nature.

[20]  Tomas C. Bellamy,et al.  Ectopic release of glutamate contributes to spillover at parallel fibre synapses in the cerebellum , 2014, The Journal of physiology.

[21]  M. Weinstein,et al.  Economic Burden of Childhood Autism Spectrum Disorders , 2014, Pediatrics.

[22]  G. Barker,et al.  Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study , 2014, Translational Psychiatry.

[23]  Donald C. Rojas,et al.  Decreased left perisylvian GABA concentration in children with autism and unaffected siblings , 2014, NeuroImage.

[24]  A. Ghanizadeh.  Increased Glutamate and Homocysteine and Decreased Glutamine Levels in Autism: A Review and Strategies for Future Studies of Amino Acids in Autism , 2013, Disease markers.

[25]  Geir Bjorklund,et al.  The role of zinc and copper in autism spectrum disorders. , 2013, Acta neurobiologiae experimentalis.

[26]  M. A. Bell,et al.  Associations Between Temperament and Social Responsiveness in Young Children. , 2013, Infant and child development.

[27]  T. Croudace,et al.  Reliability Generalization for Childhood Autism Rating Scale , 2013, Journal of Autism and Developmental Disorders.

[28]  K. Hashimoto,et al.  Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism , 2013, Molecular Autism.

[29]  M. Reber.  The Autism Spectrum: Scientific Foundations and Treatment , 2012 .

[30]  David J. Nutt,et al.  GABA system dysfunction in autism and related disorders: From synapse to symptoms , 2012, Neuroscience & Biobehavioral Reviews.

[31]  Y. S. Kim,et al.  Global Prevalence of Autism and Other Pervasive Developmental Disorders , 2012, Autism research : official journal of the International Society for Autism Research.

[32]  S. Warren,et al.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective. , 2012, Annual review of pathology.

[33]  U. Rajamma,et al.  Glutamate mediated signaling in the pathophysiology of autism spectrum disorders , 2012, Pharmacology Biochemistry and Behavior.

[34]  C. Pittenger,et al.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. , 2011, Pharmacology & therapeutics.

[35]  L. Zwaigenbaum,et al.  Differentiating autism spectrum disorder from other developmental delays in the first two years of life. , 2011, Developmental disabilities research reviews.

[36]  Yosuke Kameno,et al.  Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism , 2011, PloS one.

[37]  E. Rossignol,et al.  Genetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders , 2011, Neural plasticity.

[38]  M. Fagiolini,et al.  Autism: A “Critical Period” Disorder? , 2011, Neural plasticity.

[39]  Marianne L. Barton,et al.  Using the Childhood Autism Rating Scale to Diagnose Autism Spectrum Disorders , 2010, Journal of autism and developmental disorders.

[40]  L. Ballerini,et al.  GABAergic and glycinergic interneuron expression during spinal cord development: Dynamic interplay between inhibition and excitation in the control of ventral network outputs , 2009, Progress in Neurobiology.

[41]  Nathalie Boddaert,et al.  MRI Findings in 77 Children with Non-Syndromic Autistic Disorder , 2009, PloS one.

[42]  S. Fatemi.  The hyperglutamatergic hypothesis of autism , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  Yingye Zheng,et al.  Integrating the predictiveness of a marker with its performance as a classifier. , 2007, American journal of epidemiology.

[44]  Yoshio Minabe,et al.  Increased serum levels of glutamate in adult patients with autism , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[45]  S. Lovestone,et al.  Proteome-based plasma biomarkers for Alzheimer's disease. , 2006, Brain : a journal of neurology.

[46]  M. Rutter,et al.  Autism Research: Lessons from the Past and Prospects for the Future , 2005, Journal of autism and developmental disorders.

[47]  M. Simard,et al.  The neurobiology of glia in the context of water and ion homeostasis , 2004, Neuroscience.

[48]  D. Javitt,et al.  Glutamate as a therapeutic target in psychiatric disorders , 2004, Molecular Psychiatry.

[49]  Maurice Place,et al.  The developmental, dimensional and diagnostic interview (3di): a novel computerized assessment for autism spectrum disorders. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  Vera Mihajlovic‐Madzarevic,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, JAMA.

[51]  Arnold R. Kriegstein,et al.  Is there more to gaba than synaptic inhibition? , 2002, Nature Reviews Neuroscience.

[52]  R. Prost,et al.  Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. , 2001, AJNR. American journal of neuroradiology.

[53]  B. Bode.  Recent molecular advances in mammalian glutamine transport. , 2001, The Journal of nutrition.

[54]  Wolzt,et al.  World Medical Association Declaration of Helsinki , 2000, International Journal of Pharmaceutical Medicine.

[55]  W. Chan,et al.  Neurotransmitters, Neuropeptides and Calcium Binding Proteins in Developing Human Cerebellum: A Review , 2000, The Histochemical Journal.

[56]  M. Cuénod,et al.  Glutamine as precursor for the GABA and glutamate trasmitter pools , 1978, Neuroscience Letters.

[57]  M. Rutter,et al.  Autism: A Reappraisal of Concepts and Treatment , 1978 .

[58]  Salvatore Chirumbolo,et al.  Immune dysfunction and neuroinflammation in autism spectrum disorder. , 2016, Acta neurobiologiae experimentalis.

[59]  S. Fatemi,et al.  The Molecular Basis of Autism , 2015, Contemporary Clinical Neuroscience.

[60]  P. Good.  Does infectious fever relieve autistic behavior by releasing glutamine from skeletal muscles as provisional fuel? , 2013, Medical hypotheses.

[61]  S. Bhalerao,et al.  Sample size calculation , 2010, International journal of Ayurveda research.

[62]  J. Viña,et al.  Structure of the blood-brain barrier and its role in the transport of amino acids. , 2006, The Journal of nutrition.

[63]  Y. Moriyama,et al.  Synaptic-like microvesicles, synaptic vesicle counterparts in endocrine cells, are involved in a novel regulatory mechanism for the synthesis and secretion of hormones. , 2000, The Journal of experimental biology.